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Abstract The acidic (A) region of WASp family proteins is
thought to represent a high-affinity binding site for Arp2/3
complex without activating properties. Here we show that GST-
fused WASp-A and N-WASP-A, but not a WASP-A/W500S
mutant, several truncated WASp-A constructs or WAVE1-A can
pull down Arp2/3 complex from cell lysates. Significantly,
WASp-A and N-WASP-A synergistically trigger formation of
filopodia or lamellipodia when coinjected with sub-effective
concentrations of V12CDC42Hs or V12Rac1, respectively, into
macrophages. The ability of WASp family A region constructs to
induce this effect is closely correlated with their ability to bind
Arp2/3 complex in vitro. These results imply that (i) Arp2/3
complex is critically involved in filopodia and lamellipodia
formation in macrophages and (ii) acidic regions of WASp and
N-WASP are not simply binding sites for Arp2/3 complex but
can prime it for RhoGTPase-triggered signals leading to actin
nucleation. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Arp2/3 complex has been implicated in the formation of
f-actin structures like lamellipodia [1], podosomes [2], comet
tails of Listeria [3] (reviewed in [4]) and Shigella [5] (reviewed
in [4]), and phagocytic uptake structures [6^8].
The human WASp family comprises WASp, N-WASp and
three WAVE/Scar isoforms and is thought to link RhoGTP-
ase-mediated signal transduction to actin nucleation via
Arp2/3 complex (reviewed in [9^11]). For example, CDC42
has been shown to trigger formation of ¢lopodia [12^14] (re-
viewed in [11,15]), while Rac mediates formation of lamelli-
podia/ru¥es via WASp family proteins [16,17] (reviewed in
[11,15]).
The isolated C-terminal VCA domain of WASp family pro-
teins, containing verprolin-like, central and acidic regions
(Fig. 1A), binds both actin and Arp2/3 complex and activates
Arp2/3 complex in vitro and in vivo [18^21]. Binding of
monomeric actin is mostly achieved through the V region,
while both the C and A regions mediate binding to Arp2/3
complex [21,22].
Binding to members of the Wiskott^Aldrich syndrome pro-
tein (WASp) family transforms the basally inactive Arp2/3
complex into a highly e⁄cient nucleator of actin ¢laments
that grow from their barbed ends (reviewed in [9^11]). In
this context, the C-terminal acidic (A) region of WASp family
proteins is thought to represent a high-a⁄nity binding site for
Arp2/3 complex without activating properties ([18,19], re-
viewed in [9]).
Recently, WASp-VC was shown to be the minimal neces-
sary region for Arp2/3 complex activation in vitro and in cells
[22]. Furthermore, GST fusions of the CA or C regions lead
to actin aggregation in cells upon microinjection [22]. This
leaves the Arp2/3 complex binding A region of WASp as a
potential tool to probe Arp2/3 complex involvement in cellu-
lar processes. This study was therefore set up to explore in
greater detail the Arp2/3 binding abilities of acidic regions of
WASp family proteins (Fig. 1B).
2. Materials and methods
2.1. Cell isolation and culture
Human peripheral blood leukocytes were isolated by centrifugation
of heparinized blood in Ficoll (Biochrom, Berlin, Germany). Mono-
cytic cells were isolated with magnetic anti-CD14 antibody beads and
an MS+ separation column (Miltenyi Biotec, Auburn, CA, USA) ac-
cording to the manufacturer’s instructions and seeded onto Cellocate
coverslips (Eppendorf, Hamburg, Germany) at a density of 5U104 per
coverslip. Cells were cultured in RPMI containing 20% autologous
serum at 37‡C, 5% CO2 and 90% humidity. Medium was changed
every 3^4 days.
2.2. Generation of constructs and protein expression
WASp constructs were created by cloning PCR-generated inserts (in
the case of WASp-CA and WASp-A constructs) or commercially syn-
thesized oligonucleotides (MWG Biotech, Germany) in the case of
WASp-A13, WASp-A11, WASp-A9, WASp-A7 and WASpA/W500S
into the BamHI and EcoRI sites of vector pGEX-2T (Amersham
Pharmacia Biotech, Uppsala, Sweden), as in part described earlier
[2,23]. Vectors for expression of V12CDC42Hs and V12Rac1 were
kind gifts of Dr. A. Hall (London, UK). Proteins were expressed as
glutathione S-transferase (GST) fusion proteins in Escherichia coli as
described [23]. When indicated, GST was removed by thrombin cleav-
age, according to the manufacturer’s instructions. For microinjection,
proteins were dialyzed against microinjection bu¡er (50 mM Tris^
HCl, 150 mM NaCl, 5 mM MgCl2), concentrated in Centricon ¢lters
(Millipore, Bedford, MA, USA), shock-frozen and stored at 380‡C.
Purity was tested by SDS^PAGE and Coomassie staining. For aniso-
tropy experiments, GST fusions of the WASp acidic region were pu-
ri¢ed by FPLC, as described [22].
2.3. GST pull down assay and immunoblotting
GST pull downs were prepared as described previously [2]. Brie£y,
a total of 3U106 cells cultured for 5^14 days in six well plates (Nunc)
at a density of 1U106 cells/well were washed in ice-cold phosphate-
bu¡ered saline (PBS) and lysed by the addition of 200 Wl/well RIPA
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bu¡er (20 mM Tris^HCl, pH 8.0, 1 mM EDTA, 1% Triton X-100, 75
mM NaCl2) containing protease inhibitors. After centrifugation
(15 000 rpm, 15 min, 4‡C), aliquots of the supernatant were added
to glutathione Sepharose beads, previously incubated for 1 h with 50
Wg of GST fusion proteins. Beads were incubated with lysate for 30
min at 4‡C, washed extensively in RIPA bu¡er and pelleted. 100 Wl of
SDS sample bu¡er was added, and an aliquot was run on a 12.5%
SDS gel. Western blots were prepared as described previously [23].
Arp2/3 complex was detected by using polyclonal anti-ARPC1 and -
ARPC2 antibodies [2]. Secondary antibody was horseradish peroxi-
dase-conjugated (Amersham Pharmacia Biotech). No binding of the
screened proteins was detected when GST alone was bound to beads.
2.4. Fluorescence anisotropy measurements
Experiments were conducted as described elsewhere [22]. Brie£y, 0.1
WM of rhodamine-labeled WASp VCA (without GST), 0.1 WM Arp2/3
complex and varying concentrations of binding partners were incu-
bated in 20 nM imidazole, pH 7.0, 50 mM KCl, 1 mM MgCl2, 1 mM
EGTA, 0.025% Thesit (Roche Molecular Biochemicals, Basel, Swit-
zerland) for 2 min at room temperature. Fluorescence anisotropy was
measured in an Alpha-scan spectro£uorimeter (Photon Technologies
International) at 552 nm excitation at 574 nm emission and plotted in
arbitrary units. Dissociation equilibrium constants (Kd) were calcu-
lated as described earlier [21]. GST controls showed no e¡ect in the
anisotropy measurements. Arp2/3 complex was prepared from bovine
thymus as described [24].
2.5. Microinjection of proteins
Cells for microinjection experiments were cultured for 5^8 days.
Microinjection was performed using transjector 5246 (Eppendorf)
and a Compic Inject micromanipulator (Cell Biology Trading, Ham-
burg, Germany). GST fusions of WASp C-terminal regions, GST-
V12CDC42 and GST-free V12Rac were injected at the indicated con-
centrations. Cells were incubated for 1 h post injection. Control in-
jections were performed with GST alone. Injected cells were identi¢ed
by detection of coinjected rat IgG (5 mg/ml) with FITC-labeled goat
anti-rat IgG antibody (both Dianova, Hamburg, Germany).
2.6. Immuno£uorescence microscopy
For actin and Arp2/3 complex staining, cells were grown on cover-
slips for 5^8 days and microinjected when indicated. Samples were
then ¢xed for 10 min in PBS solution containing 3.7% formaldehyde
and permeabilized for 5 min in ice-cold acetone. Background £uores-
cence was reduced by incubating coverslips with 5% human serum and
5% normal goat serum (both Dianova) in PBS. Actin was detected
with Alexa 568-labeled phalloidin (Molecular Probes, Leiden, The
Netherlands) or with monoclonal antibody MAB1501 (Chemicon,
Temecula, CA, USA), Arp2/3 complex was detected by staining
with anti-ARPC2 antibody [2]. Secondary antibody was Alexa 488-
labeled goat anti-rabbit (Molecular Probes). Coverslips were mounted
in Mowiol (Calbiochem, Schwalbach, Germany), containing p-phenyl-
enediamine (Sigma, Deisenhofen, Germany) as anti-fading reagent,
and sealed with nail polish. Images were obtained either by confocal
laser scanning microscopy (Leica, Wetzlar, Germany) or with a spot
digital camera (Leica).
3. Results and discussion
To map residues of the 15 aa WASp A region necessary for
interaction with Arp2/3 complex, a series of N-terminally
truncated constructs fused to the C-terminus of GST were
created and named accordingly WASp-A13, WASp-A11,
WASp-A9 and WASp-A7 (Fig. 1C). We ¢rst assessed the
ability of these constructs to pull down Arp2/3 complex
from macrophage lysates (Fig. 2A). WASp-A was able to
pull down Arp2/3 complex, as described [2], while shorter
constructs bound with decreasing e⁄ciency. WASp-A11 dis-
played only minimal ability to pull down Arp2/3 complex,
while WASp-A7 showed no interaction in this assay (Fig.
2A). Decreasing ability to pull down Arp2/3 complex was
re£ected by decreasing a⁄nity for Arp2/3 complex in aniso-
tropy assays. For example, WASp-A15 bound Arp2/3 com-
plex with a Kd of 1.0 WM (Fig. 2C [22]), while WASp-A9
bound with a Kd of 4.0 WM (Fig. 2D). As positive and neg-
ative controls respectively, we used construct WASp-CA (Fig.
1A), comprising all known binding sites for Arp2/3 complex
in the VCA domain [21,22], and construct WASp-A/W500S
(Fig. 1C) carrying a point mutation previously shown to dras-
tically reduce the a⁄nity of WASp VCA for Arp2/3 complex
[21]. WASp-CA bound Arp2/3 complex e⁄ciently, as shown
earlier [22] (Fig. 2A), while WASp-A/W500S displayed no
detectable interaction with Arp2/3 complex in this assay
(Fig. 2A). We conclude from these experiments that, apart
from the previously identi¢ed W500 amino acid residue, also
the presence of the four N-terminal amino acid residues of the
WASp A region (aa 488^491) is critical for interaction with
Arp2/3 complex in vitro.
The A regions of WASp and N-WASP are highly homolo-
gous (11 identical amino acids; Fig. 1B), while those of
Fig. 1. Domain organization of WASp, GST fusion constructs of WASp C-terminus and comparison of acidic regions of WASp family pro-
teins. A: Domain organization of WASp: WASp homology domain 1 (WH1), basic domain (B), GTPase binding domain (GBD), polyproline
domain, C-terminal domain (containing verprolin-like (V), central C-terminal (C) and acidic (A) regions). Numbers indicate ¢rst and last amino
acids of proteins. B: Comparison of acidic regions of WASp, N-WASP and WAVE1. C: Truncated or mutated forms of the WASp A region
used in this study.
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WAVE proteins are clearly more divergent (7 homologous
amino acids in WAVE1-A compared to WASp-A; Fig. 1B).
A GST fusion of the N-WASP acidic region, N-WASP-A
(Fig. 1B), showed comparable ability to WASp-A to pull
down Arp2/3 complex from macrophage lysates (Fig. 2B),
while the respective WAVE1 construct, WAVE1-A (Fig.
1C), was barely able to do so (Fig. 2B). The high identity
of WASp and N-WASp acidic regions is therefore also mir-
rored by a functional similarity in Arp2/3 complex binding. In
contrast, the acidic region of WAVE1 seems to be necessary
[18,25], but is clearly not su⁄cient for Arp2/3 complex bind-
ing.
We went on to investigate whether formation of speci¢c
actin structures in cells is dependent on Arp2/3 complex. Mi-
croinjection of primary human macrophages with the consti-
tutively active GTPase mutants V12CDC42Hs (0.2 Wg/Wl) or
V12Rac1 (0.2 Wg/Wl) leads to formation of ¢lopodia or lamel-
lipodia/ru¥es, respectively ([23] and Linder, unpublished).
The latter e¡ect is mostly associated with cell spreading.
When microinjected at values below the e¡ective concentra-
tions, neither the GTPase mutants (V12CDC42: 0.1 Wg/Wl ;
V12Rac: 0.1 Wg/Wl ; Fig. 3A,B) nor WASp-A (4 Wg/Wl ; Fig.
3C) or N-WASP-A (4 Wg/Wl ; Fig. 3F) had a discernible ef-
fect on the actin cytoskeleton (cells showing ¢lopodia:
V12CDC42, 10 þ 9%; WASp-A, 12 þ 2%; N-WASp-A,
12 þ 4%; cells showing ru¥es: V12Rac, 3 þ 3%; WASp-
A, 0 þ 0%; N-WASp-A, 0 þ 0%; Fig. 4). However, coinjection
of WASp-A or N-WASp-A with either one of the constitu-
tively active GTPase mutants, all proteins at sub-thres-
hold concentrations, dramatically enhanced formation of ¢lo-
podia or ru¥es (Fig. 3D,E,G,H). The respective phenotype
was dependent on the GTPase mutant: coinjection with
V12CDC42Hs resulted in ¢lopodia formation (cells showing
¢lopodia: V12CDC42+WASp-A, 97 þ 6%; V12CDC42+N-
WASp-A, 96 þ 4%; Figs. 3D,G and 4), while coinjection
with V12Rac triggered formation of ru¥es and cell spread-
ing (cells showing ru¥es: V12Rac+WASp-A, 91 þ 2%;
V12Rac+N-WASp-A, 94 þ 5%; Figs. 3E,H and 4). In this
respect, the A regions of WASp and N-WASp were inter-
changeable.
In contrast, coinjection of the GTPase mutants with
WAVE1-A failed to elicit any discernible e¡ect on the actin
cytoskeleton (cells showing ¢lopodia: V12CDC42+WAVE1-
A, 8 þ 2%; cells showing ru¥es: V12Rac+WAVE1-A,
6 þ 7%; Fig. 4). In addition, WASp-A13 was able to stimulate
formation of ¢lopodia or ru¥es in coinjection experiments
(Fig. 4), although to a lesser degree compared to WASp-A,
while all shorter constructs of the WASp acidic region failed
to do so (Fig. 4 and not shown). Coinjection of GTPase con-
structs with the WASp-A/W500S mutant resulted in a marked
decrease in both ¢lopodia and ru¥e formation compared
to coinjections with WASp-A (cells showing ¢lopodia:
V12CDC42+WASp-A/W500S, 12 þ 8%; cells showing ru¥es:
V12Rac+WASp-A/W500S, 19 þ 5%; Fig. 4). Additionally, co-
injection of WASp-CA (Fig. 1A) stimulated ¢lopodia or ru¥e
formation even at concentrations of 0.5 Wg/Wl (not shown).
This requirement for lower e¡ective concentrations ¢ts well
with WASp-CA showing a 10-fold higher a⁄nity for Arp2/3
complex (Kd : 0.1 WM [22]) than WASp-A (Kd : 1 WM).
Formation of ¢lopodia or ru¥es in microinjected cells was
often accompanied by disruption of podosomes, actin-rich
adhesion structures controlled by WASp [2,23]. Therefore,
regulation of podosomes apparently di¡ers from that of ¢lo-
podia and lamellipodia. It seems that Arp2/3 complex bound
to WASp family A region constructs is not incorporated into
podosomes [2], but can be used e¡ectively by GTPase-trig-
gered pathways to induce ¢lopodia and ru¥es. These signals
may involve e.g. the CDC42-IRSp53-Mena pathway recently
shown to be important for ¢lopodia formation in Swiss 3T3
cells [26].
Fig. 2. Arp2/3 complex binding of GST fusions containing C-terminal acidic peptides of WASp family proteins. Western blots of GST pull
down experiments using (A) a series of N-terminally truncated or mutated constructs of WASp C-terminus or (B) constructs of acidic regions
of WASp family proteins, probed with ARPC1-speci¢c antibody. Denominations of polypeptides are given above each lane. Anisotropy mea-
surement of binding to Arp2/3 complex by WASp-A (C) and WASp-A9 (D) constructs. Increasing amounts of the respective construct were al-
lowed to compete with rhodamine-labeled (GST-free) WASp VCA. Decrease in anisotropy indicates successful competition by the respective
construct.
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In sum, we assessed the Arp2/3 complex binding abilities of
WASp family acidic constructs in vitro and in vivo. The acidic
regions of WASp and N-WASp, but not of WAVE1, were
found to interact e⁄ciently with Arp2/3 complex in vitro.
The four N-terminal amino acid residues of WASp-A are
crucial for this e¡ect. Signi¢cantly, we observed a synergistic
e¡ect in the formation of ¢lopodia and ru¥es when GST
fusions of the acidic regions of WASp or N-WASP were co-
injected into macrophages with constitutively active mutants
of CDC42Hs or Rac1. Coinjection with WASp-A13 also
showed a synergistic e¡ect on ¢lopodia or ru¥e formation,
although to a less marked degree compared to the full-length
WASp-A. Coinjections of GTPases with all shorter constructs
of the WASp acidic region as well as the WASp-A/W500S
construct or the WAVE-1A construct led to no signi¢cant
increase in actin structure formation. The ability of WASp
family A region constructs to induce actin structure formation
thus closely correlated with their ability to bind actin nucleat-
Fig. 3. Coinjection of WASp-A or N-WASp-A with constitutively active GTPase mutants has a synergistic e¡ect on ¢lopodia and lamellipodia
formation. A^H: Confocal laser scanning micrographs of primary human macrophages stained for f-actin 1 h post injection. Insets show stain-
ing of rat IgG used as an injection marker. V12CDC42 (A) and V12Rac (B) were injected at 0.1 Wg/Wl. WASp-A (C) and N-WASP-A (F) were
injected at 4 Wg/Wl. No e¡ect on the actin cytoskeleton was observed at these concentrations. Coinjection of V12CDC42 with WASp-A (D) or
N-WASp-A (G) at these concentrations led to prominent formation of ¢lopodia, while coinjection of V12Rac with WASp-A (E) or N-WASP-
A (H) led to formation of ru¥es and cell spreading. White bar indicates 12 Wm for E and H and 10 Wm for all others.
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ing Arp2/3 complex in vitro. Therefore, Arp2/3 complex bind-
ing is most probably a prerequisite for the observed e¡ects,
which is also indicated by the recruitment of Arp2/3 complex
to the induced structures (Fig. 5).
To elucidate the mechanism by which the observed struc-
tures are induced, we studied the distribution of WASp,
N-WASP and WAVE in uninjected cells and in cells coin-
jected with WASp-A with CDC42V12/RacV12 (not shown).
We ¢nd that, although the podosomal localization of
WASp is destroyed upon microinjection of WASp-A with
CDC42V12/RacV12, there is no signi¢cant colocalization of
endogenous WASp with either ¢lopodia or ru¥es. In a
previous study, we also found no indication for an interac-
tion of WASp-A with endogenous WASp in vitro [22]. On
the other hand, N-WASp and WAVE localize to newly
formed ¢lopodia or ru¥es, respectively. Ultimately, we can-
not rule out that WASp-A or endogenous WASp plays a
role in the generation of these structures. However, accord-
ing to our data it is likely that ¢lopodia and lamellipodia
are induced and localized by the pathways CDC42-N-
WASP-Arp2/3 complex and Rac-WAVE-Arp2/3 complex,
respectively. In this scenario, WASp-A would only induce
‘priming’ of Arp2/3 complex, which would explain the high
e⁄ciency in structure formation, while the generation of
speci¢c structures as well as their localization would not
be based on WASp-A activity.
In a recent paper, Zalevsky et al. [27] show that in a chi-
mera of the WAVE1 C-terminal domain, replacement of the
acidic region of WAVE1 with the acidic region of N-WASp
results in a 20-fold increase in actin nucleating ability. This ¢ts
well with our data that, in contrast to WASp-A and
N-WASP-A, WAVE1-A is not able to bind Arp2/3 complex
e⁄ciently in vitro or to induce actin structures upon coinjec-
tion of WASpA with CDC42V12/RacV12. It is not yet clear
where the ‘priming’ step proposed in the present paper would
¢t in the actin nucleation model presented by Zalevsky et al.
[27]. It may occur directly upon binding of WASp/N-WASp
to Arp2/3 complex but also at a later step.
Our results imply that (i) Arp2/3 complex is critically in-
volved in the generation of both ¢lopodia and ru¥es in pri-
mary human macrophages and (ii) the acidic regions of WASp
and N-WASP are not simply high-a⁄nity binding sites for
Arp2/3 complex. It may be that these regions induce a ‘prim-
ing’ step which does not lead to full activation but to height-
ened susceptibility of Arp2/3 complex for GTPase-triggered
signals to induce actin polymerization. The existence of addi-
tional activation steps in actin nucleating pathways has al-
ready been speculated upon [21]. Our results give the ¢rst
indication at the cellular level that at least one such additional
step may in fact exist. The acidic region constructs used in this
study may also be helpful tools in further addressing this issue
and also whether actin-dependent processes in cells are Arp2/3
complex-dependent.
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